Search clinical trials for: investigational drug INGN 241

Total 2285 results

Intrepid Therapeutics, Inc.

Completed

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Brown University
Actuate Therapeutics Inc.

Withdrawn

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma

Soft Tissue Sarcoma | Osteosarcoma | Ewing Sarcoma of Bone | Leiomyosarcoma | High Grade Sarcoma | Liposarcoma | Rhabdomyosarcoma | Angiosarcoma | Bone Sarcoma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Myxofibrosarcoma | Spindle Cell Sarcoma

United States
Brown University
Actuate Therapeutics Inc.

Withdrawn

A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas

Sarcoma | Soft Tissue Sarcoma | Leiomyosarcoma | High Grade Sarcoma | Liposarcoma | Rhabdomyosarcoma | Angiosarcoma | Bone Sarcoma | Synovial Sarcoma | Undifferentiated Pleomorphic Sarcoma | Metastatic Sarcoma | Myxofibrosarcoma | Spindle Cell Sarcoma

United States
Ocumension Therapeutics (Shanghai) Co., Ltd

Completed

Study of Dexycu in Treating Intraocular Inflammation

Inflammation | Cataract

China
Kiomed Pharma

Unknown

sAfety PerfoRmance chitOsan osteOarthritis ViscosupplEmentation (APROOVE)

Knee Osteoarthritis
GE Healthcare
Karolinska University Hospital

Recruiting

Clinical Data Collection On Advanced CT System

CT Photon Counting

Sweden
Assiut University

Not yet recruiting

Risk Factors of Thrombocytopenia In Chronic Kidney Disease And Hemodialysis Patients In Assiut University Hospitals

Thrombocytopenia in CKD
pH Pharma

Completed

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Normal Tension Glaucoma

Korea, Republic of
International AIDS Vaccine Initiative
Polymun Scientific GmbH

Not yet recruiting

Mosaic HIV-1 Envelope Trimer Immunogens Administered to People Living With HIV (PLWH) in Africa (C112)

HIV

Uganda, Zambia
University of Missouri-Columbia

Suspended

n-3 Polyunsaturated Fatty Acids to Prevent and Treat Diabetic Neuropathy (NMF)

Diabetic Neuropathies

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With Chemotherapy

Lymphoma, B-Cell

United States
Xijing Hospital

Recruiting

Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

China
United BioPharma
National Taiwan University Hospital; Kaohsiung Medical University Chung-Ho... and other collaborators

Completed

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients

HIV-1 Infection

Taiwan
Sinovac Research and Development Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
Lumos Pharma

Active, not recruiting

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) (OraGrowtH213)

Growth Hormone Deficiency

United States, Poland
HilleVax

Completed

Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

Gastroenteritis

United States
Tarveda Therapeutics

Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Carcinoma, Small Cell Lung

United States, United Kingdom
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Completed

Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants

Mumps

China
University of Milano Bicocca

Completed

Screening of Health-care Workers in an University Hospital for SARS-CoV-2 (STORM-HCW)

Covid19

Italy
Rapa Therapeutics LLC
Medical College of Wisconsin

Recruiting

RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma

Relapsed, Refractory Multiple Myeloma

United States
Biocad

Recruiting

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Neuroblastoma

Russian Federation
Lumos Pharma

Enrolling by invitation

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) (OraGrowtH211)

Growth Hormone Deficiency

United States, Australia
United BioPharma

Completed

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients

Urticaria Chronic

Taiwan
Lumos Pharma

Active, not recruiting

PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) (OraGrowtH212)

Growth Hormone Deficiency

Chile
AbbVie

Terminated

A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor

Glioblastoma Multiforme | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Colorectal Carcinoma

United States, Spain
Sohag University

Not yet recruiting

Acute Pancreatitis : Comparison of Various Scores in Predicting Severity and Outcome

Acute Pancreatitis
Celgene

Terminated

Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.; Jiangsu Province Center for...

Active, not recruiting

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine

Varicella

China
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients (HIV-1)

HIV-1-infection
UBP Greater China (Shanghai) Co., Ltd

Not yet recruiting

A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir

HIV-1-infection
Johns Hopkins University

Available

Expanded Access Protocol Using HBOC-201

Anemia

United States
Stairway Medical AB
Lund University; Skane University Hospital

Not yet recruiting

Evaluation of Medical Device for Airway Patency During Sedation (SW01-2022)

Hypoxia | Airway Obstruction | Patient Satisfaction | Safety Issues | Work Related Stress | Sedation Complication | Complication of Treatment | Breathing Arrested
Haemonetics Corporation

Completed

Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution

Blood Donors

United States
Procter & Gamble Beauty

Completed

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis

Eczema | Dermatitis, Atopic

United States
M.D. Anderson Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

United States
IVI Bilbao

Terminated

Influence Instillation Plasma Rich in Growth Factors in Endometrial Cavity Endometrial Development in Assisted Reproduction.

Endometrial Development

Spain
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

Virus Diseases

Mali, Senegal, Cameroon, Nigeria
Suzhou Connect Biopharmaceuticals, Ltd.

Completed

A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects

Healthy Adult Subjects

China
Rockefeller University

Completed

A Study Investigating the Safety and Tolerability of an Immune Treatment in Cancer Patients With Lesions to the Skin

Cancer | Solid Tumor | Cancer of Skin

United States
OncoC4, Inc.

Withdrawn

Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841

Advanced Solid Tumor
HilleVax

Active, not recruiting

Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants

Gastroenteritis

Japan
Phage Pharmaceuticals, Inc.

Unknown

Safety Study of Topical Human FGF-1 for Wound Healing

Diabetic Foot Ulcers

United States
TWi Biotechnology, Inc.

Completed

A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout

Gout

Taiwan
Chong Kun Dang Pharmaceutical
Severance Hospital

Not yet recruiting

The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1

Early Puberty

Korea, Republic of
Ocumension (Hong Kong) Limited
ORA, Inc.; Statistics & Data Corporation

Active, not recruiting

Study of OT-101 in Treating Myopia

Myopia, Progressive

United States
Abbott Medical Optics

Completed

Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD)

Cataract

United States
Far Eastern Memorial Hospital

Completed

The CZT Dynamic Myocardial Perfusion Imaging (CZT)

Cardiac Disease

Taiwan
4SC AG

Completed

Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma (SAPHIRE)

Hodgkin's Lymphoma

Poland, Czech Republic, Romania
University of Michigan
Food and Drug Administration (FDA)

Completed

Correlation of Mesalamine Pharmacokinetics With Local Availability

Local Drug Concentration in Gastrointestinal Tract

United States
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Recurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...

United States

Search clinical trials for: investigational drug INGN 241

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations